Cargando…

Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning

The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of fami...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieni, Elena, Cetica, Valentina, Hackmann, Yvonne, Coniglio, Maria Luisa, Da Ros, Martina, Ciambotti, Benedetta, Pende, Daniela, Griffiths, Gillian, Aricò, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997030/
https://www.ncbi.nlm.nih.gov/pubmed/24795715
http://dx.doi.org/10.3389/fimmu.2014.00167
_version_ 1782313136369434624
author Sieni, Elena
Cetica, Valentina
Hackmann, Yvonne
Coniglio, Maria Luisa
Da Ros, Martina
Ciambotti, Benedetta
Pende, Daniela
Griffiths, Gillian
Aricò, Maurizio
author_facet Sieni, Elena
Cetica, Valentina
Hackmann, Yvonne
Coniglio, Maria Luisa
Da Ros, Martina
Ciambotti, Benedetta
Pende, Daniela
Griffiths, Gillian
Aricò, Maurizio
author_sort Sieni, Elena
collection PubMed
description The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes.
format Online
Article
Text
id pubmed-3997030
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-39970302014-05-02 Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning Sieni, Elena Cetica, Valentina Hackmann, Yvonne Coniglio, Maria Luisa Da Ros, Martina Ciambotti, Benedetta Pende, Daniela Griffiths, Gillian Aricò, Maurizio Front Immunol Immunology The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes. Frontiers Media S.A. 2014-04-16 /pmc/articles/PMC3997030/ /pubmed/24795715 http://dx.doi.org/10.3389/fimmu.2014.00167 Text en Copyright © 2014 Sieni, Cetica, Hackmann, Coniglio, Da Ros, Ciambotti, Pende, Griffiths and Aricò. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Sieni, Elena
Cetica, Valentina
Hackmann, Yvonne
Coniglio, Maria Luisa
Da Ros, Martina
Ciambotti, Benedetta
Pende, Daniela
Griffiths, Gillian
Aricò, Maurizio
Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
title Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
title_full Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
title_fullStr Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
title_full_unstemmed Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
title_short Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
title_sort familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997030/
https://www.ncbi.nlm.nih.gov/pubmed/24795715
http://dx.doi.org/10.3389/fimmu.2014.00167
work_keys_str_mv AT sienielena familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning
AT ceticavalentina familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning
AT hackmannyvonne familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning
AT conigliomarialuisa familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning
AT darosmartina familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning
AT ciambottibenedetta familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning
AT pendedaniela familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning
AT griffithsgillian familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning
AT aricomaurizio familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning